Drug Information

Drug General Information
Drug ID
D0B1CF
Former ID
DIB014913
Drug Name
PharmaPEG-EPO
Synonyms
Pegylated erythropoietin (hematological disease/immune disorder), Mountain View Pharmaceuticals; PharmaPEG-EPO (hematological disease/immune disorder); PharmaPEG-EPO (hematological disease/immune disorder), Mountain View Pharmaceuticals
Indication Hematological disease [ICD10:D50-D89] Investigative [543465]
Company
Mountain View Pharmaceuticals Inc
Target and Pathway
Target(s) Erythropoietin Receptor Target Info Modulator [543465]
KEGG Pathway Cytokine-cytokine receptor interaction
PI3K-Akt signaling pathway
Jak-STAT signaling pathway
Hematopoietic cell lineage
NetPath Pathway TGF_beta_Receptor Signaling Pathway
Pathway Interaction Database Signaling events mediated by Stem cell factor receptor (c-Kit)
EPO signaling pathway
WikiPathways EPO Receptor Signaling
References
Ref 543465(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1718).
Ref 543465(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1718).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.